Article
Genetic Variants at the NAT2 and HLA-DOA are Associated With Anti-Tuberculosis Drug-Induced Liver Injury Susceptibility and Clinical Manifestations in Western Chinese Populations.
Immunity, inflammation and disease - 1 Sept 2026
Zhao Zhenzhen, Wang Dongmei, Si Yanjun, Zhou Yanhong, Ruan Hongxia, Ying Binwu, Chen Hao
Abstract excerpt
BACKGROUND: Anti-tuberculosis drug-induced liver injury (ATDILI) is one of the most prevalent and serious adverse reactions during anti-tuberculosis treatment and can potentially lead to liver failure or mortality. This study aims to investigate whether genetic variants in the N-acetyltransferase 2 gene (NAT2) and the HLA-DOA gene (HLA-DOA) are associated with ATDILI susceptibility and clinical manifestations in...
Read the complete abstract on PubMedTopics
- Adult
- Female
- Humans
- Male
- Middle Aged
- Antitubercular Agents
